Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

dollar money graph increase finance

Billing claims for nonphysician image interpretation leapt 27% over a 5-year period

"Since several states are shifting toward granting NPPs more autonomy, this is something worth watching," the study's author told Radiology Business

artificial intelligence industry watchers digest

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

Thumbnail

Imaging AI vendors’ marketing hype doesn’t always match materials submitted to the FDA

About 1 in 8 were discovered to have marketing materials that made claims differing from their premarket approval. 

American Medical Association issues CPT code for AI-based brain MRI software

Icometrix said the current procedural terminology code covers its FDA-cleared quantification software, “creating a path to reimbursement.” 

Cost of healthcare expected to increase by 7% in 2024

The estimated increase is driven by multiple factors, including labor shortages, provider contract negotiations and rising drug prices.

FDA approves Abbott’s Aveir dual chamber (DR) leadless pacemaker system, the world’s very first dual chamber leadless pacing solution for treating patients with abnormal heart rhythms.

FDA approves world’s first dual-chamber leadless pacemaker system

The minimally invasive system is made up of two pacemakers that send signals back and forth to one another. One pacemaker is placed on the patient's right ventricle, and the other is placed on the patient's right atrium. 

Thumbnail

Cardiology societies say affirmative action ruling will do long-term damage to patient care

The American College of Cardiology, Association of Black Cardiologists and several other U.S. societies released a new joint statement on the ruling.

Thumbnail

Private equity could face more scrutiny as FTC turns up the dial on merger reviews

Both the complexity and volume of deals has soared in recent years, the agency noted, prompting the need to review premerger forms for the first time in years.